0%

est. 2Y upside i

HealthcareSeries B

Rank

#2093

Sector

Healthcare Technology Systems

Est. Liquidity

~3Y

Data Quality

Data: Low

Given the severe lack of financial data (no valuation, revenue, or growth rate), this equity analysis is highly uncertain.

Last updated: July 19, 2026

Bull (20%)0%

Insufficient data to compute upside. If valuation were 30M (based on typical Series A), bull could reach 150M in 2 years, but no revenue base to validate.

Base (50%)0%

Base case uncertain due to stale round and no financials. Assuming gradual growth but limited near-term liquidity.

Bear (30%)-100%

If exit value below 10M funding, common stock returns -100% due to preference stack. High risk of failure given stale financing.

Est. time to liquidity~3.0 years

Preference Stack Risk

high

Funding Intensity

100%

Total funding of $10M implies significant preference overhang if valuation is near that amount; common stock likely worthless in exit below $10M.

Dilution Risk

high

Likely need to raise capital within 12-18 months, diluting current equity by an estimated 20% or more.

Secondary Liquidity

none

No secondary market implied; no data on employee liquidity options.

Other — 2 roles

View all 2 open roles at SiteRx →

Last updated: February 22, 2026

Questions to Ask at the Interview

Strategic questions based on SiteRx's data — designed to show you've done your homework.

  • 1

    “What is the company's current annual recurring revenue and growth rate?”

  • 2

    “When was the last financing round and at what valuation?”

  • 3

    “What is the expected cash runway and are there plans to raise more capital?”

  • 4

    “How does SiteRx differentiate from larger incumbents like CROs expanding into patient matching?”

  • 5

    “What is the target liquidity event timeline (IPO or acquisition)?”

Community

Valuation Sentiment

Our model estimates 0% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.